The effect of GLP-1 receptor agonist and SGLT2 inhibitor on infection risk: network meta-analysis | Synapse
March 3, 2026Open Access
The effect of GLP-1 receptor agonist and SGLT2 inhibitor on infection risk: network meta-analysis
Key Points
No significant evidence of increased infection risk was found related to GLP-1 receptor agonist or SGLT2 inhibitor use.
The analysis included multiple studies, showcasing the overall safety profile of these medications.
Network meta-analysis was applied to synthesize data from various clinical trials effectively.
Findings suggest that prescribing GLP-1 receptor agonists or SGLT2 inhibitors does not elevate infection risk.
Abstract
This analysis identifies no significant evidence of infection-related adverse events related to GLP-1 receptor agonist or SGLT2 inhibitor prescription.